We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBLB:EURONEXT BRUSSELSGroupe Bruxelles Lambert SA Analysis

Data as of 2026-03-14 - not real-time

$91.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Groupe Bruxelles Lambert is trading at its 20‑day simple moving average with a bullish trend direction and rising volume, suggesting short‑term buying pressure. The price is perched on a key support around €91 and faces resistance near €100, while the RSI sits in the mid‑30s, hinting at modest oversold conditions. However, the MACD histogram remains negative, signaling lingering bearish momentum. On the fundamentals side, the stock offers an attractive dividend yield of about 6 % but the payout ratio exceeds 400 %, raising concerns about sustainability. The price‑to‑earnings multiple is roughly five times the industry average, pointing to significant overvaluation despite a price‑to‑book below 1. Recent news of the group divesting its stake in Umicore reflects a strategic portfolio simplification that could improve focus but also reduces exposure to a high‑margin business.
The risk profile is marked by high 30‑day volatility and limited liquidity, while beta is near zero, indicating low market correlation. Sector‑specific regulatory and geographic exposures are moderate, but the combination of an inflated valuation, unsustainable dividend policy, and volatile price action suggests a cautious stance. Investors may consider holding for the near term while monitoring earnings trends and cash‑flow generation before committing to a longer‑term position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish trend and rising volume
  • RSI indicating near‑oversold conditions
  • Negative MACD histogram suggesting caution

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High PE relative to industry peers
  • Unsustainable dividend payout ratio
  • Portfolio simplification through Umicore sale

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation
  • Lack of earnings growth and zero ROE
  • Elevated volatility and liquidity constraints

Key Metrics & Analysis

Financial Health

Profit Margin-2.00%
P/E Ratio78.4
Debt/Equity53.49
P/B Ratio0.8
Industry P/E16.4

Technical Analysis

TrendBullish
RSI36.5
Support$91.00
Resistance$100.00
MA 20$95.90
MA 50$93.59
MA 200$88.43
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeOvervalued
TypeValue
Dividend Yield6.10%

Risk Assessment

Beta-0.02
Volatility31.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.